A COPD & Lung Disease programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €18,000–€35,000 in the United States. About 11.5h from New York, inside the EU, visa-free.
If you are researching COPD & Lung Disease treatment from the United States, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €18,000–€35,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Intravenous and nebulised MSC/exosome protocols aim to reduce airway inflammation and support lung tissue in COPD, as an adjunct to standard respiratory care. It is delivered under a physician-led protocol and designed to complement your existing care.
| United States (home) | Stem Plus · EU | |
|---|---|---|
| COPD & Lung Disease treatment | €18,000–€35,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 11.5h from New York | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
Medicina rigenerativa certificata GMP nel cuore dell'UE — da 3.000–8.000 €, una frazione dei prezzi USA o tedeschi. Protocolli personalizzati per pazienti da oltre 50 Paesi.
Valutazione medica gratuita